| NCT ID | Title | Condition | Status |
|---|---|---|---|
| Phase 2 | |||
| NCT06906562 | A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult… | Advanced Pancreatic Carcinoma | Recruiting |
| NCT06728410 | A Phase II Study of Pemigatinib Plus Durvalumab in Previously Treated Advanced… | Intrahepatic Cholangiocarcinoma | Recruiting |
| NCT07434843 | PH 2 Pemigatinib in SDH-deficient GIST | SDH Gene Mutation | Recruiting |
| Phase 1/2 | |||
| NCT06439485 | Phase I/II Trial of Pemigatinib in Combination With Atezolizumab and Bevacizumab for… | Advanced Cholangiocarcinoma | Recruiting |
| Phase 1 | |||
| NCT06302621 | Pemigatinib + Afatinib in Advanced Refractory Solid Tumors | Advanced Solid Tumor | Recruiting |